Live feed16:00:03·3dINSIDERFilingvia QuantisnowChief Development Officer Yeleswaram Krishnaswamy sold $2,531,582 worth of shares (50,160 units at $50.47) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 195,862 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
